1. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis;C, Le Roy E.C.Krieg T.Black;J Rheumatol,1988
2. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma;M, Douvas A.S.Achten M.Tan E.;J Biol Chem,1979
3. High titers of autoantibodies to topoisomerase I (Scl-70) in sera from scleroderma patients;C, Shero J.Bordwell B.Rothfield N.F.Earnshaw W.;Science,1986
4. Diversity of antinuclear antibodies in progressive systemic sclerosis. Anti-centromere antibody and its relationship to CREST syndrome;M, Tan E.; P, Rodnan G.; I, Garcia; Y, Moroi; J, Fritzler M.; C, Peebles;Arthritis Rheum,1980
5. Frequency and clinical significance of anticentromere and anti-Scl-70 antibodies in an English connective tissue disease population;J, Catoggio L.; P, Skinner R.; J, Maddison P.;Rheumatol Int,1983